STIF 56.650 € (-0,61 %)
CVC CAPITAL 12.750 € (-0,31 %)
CRCAM NORD CCI 36.240 € (-0,81 %)
FDJ UNITED 22.630 € (-0,35 %)
AYVENS 11.000 € (-1,87 %)
TONNER DRONES 0.035 € (-1,71 %)
BANIJAY GROUP 8.660 € (+0,46 %)
BOUYGUES 50.160 € (0,00 %)
CREDIT AGRICOLE 16.335 € (-1,18 %)
AIR LIQUIDE 166.860 € (-9,02 %)
TOTALENERGIES 78.650 € (+1,65 %)
LVMH 472.000 € (-1,47 %)
MEDIANTECHNOLOGIES 5.150 € (-2,28 %)
SPIE 47.680 € (-1,37 %)
PERNOD RICARD 62.600 € (+0,81 %)
SAFRAN 287.300 € (-3,75 %)
CELLECTIS 2.608 € (-1,21 %)
GENFIT 8.550 € (-2,51 %)
SAINT GOBAIN 73.680 € (-4,63 %)
SOCIETE GENERALE 69.080 € (-1,68 %)
CBI 0.074 € (0,00 %)
ORANGE 17.735 € (+1,72 %)
EXOR NV 65.750 € (+0,08 %)
ABN AMRO BANK N.V. 33.430 € (-1,15 %)
STMICROELECTRONICS 60.810 € (-3,20 %)
ARKEMA 58.750 € (-2,16 %)
ASML HOLDING 1 413.000 € (-3,36 %)
AIRBUS 173.060 € (-3,30 %)
SCHNEIDER ELECTRIC 263.850 € (-1,93 %)
EUROFINS SCIENT. 64.380 € (-0,83 %)
AHOLD DEL 35.320 € (-1,48 %)
EDP 4.433 € (+0,23 %)
SANOFI 77.940 € (-0,01 %)
DASSAULT SYSTEMES 19.420 € (-1,50 %)
CLARIANE 3.956 € (-0,70 %)
BASIC-FIT 28.740 € (-1,78 %)
ADOCIA 4.362 € (+1,92 %)
CAPGEMINI 100.550 € (-1,23 %)
ADYEN 824.000 € (+0,81 %)
ARCELORMITTAL SA 57.640 € (-2,67 %)
NEXANS 151.600 € (-2,07 %)
DANONE 64.540 € (+0,19 %)
FIGEAC AERO 10.580 € (-2,94 %)
TF1 6.740 € (-0,66 %)
DSM FIRMENICH AG 66.100 € (-2,71 %)
SPINEWAY 0.130 € (+2,05 %)
BNP PARIBAS ACT.A 91.950 € (-1,82 %)
FUGRO 11.550 € (-1,11 %)
TEIXEIRA DUARTE 0.405 € (-2,99 %)
AMUNDI 84.650 € (-0,59 %)
PROSUS 39.785 € (-0,91 %)
ING GROEP N.V. 25.635 € (-1,29 %)
NEDAP 96.200 € (-1,94 %)
BE SEMICONDUCTOR 258.800 € (-4,64 %)
VALLOUREC 24.440 € (+0,45 %)
THALES 229.300 € (-1,33 %)
HAFFNER ENERGY 0.216 € (-4,22 %)
ASM INTERNATIONAL 837.200 € (-3,44 %)
PHARMING GROUP 1.106 € (-1,07 %)
AB SCIENCE 0.903 € (-0,77 %) |
26/05/2026 18:00
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLCLeuven, BELGIUM – May 26, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on May 22, 2026, from Atlas Special Opportunities II, LLC indicating that as of May 21, 2026, it held 4,320,175 shares of the then outstanding 88,691,312 shares, and therefore crossed under the threshold (5%) by virtue of the sales of voting securities. About Oxurion Oxurion NV (Euronext Brussels: OXUR) is a company specializing in acquiring majority stakes in promising European pharmaceutical subcontractors. Oxurion's ambition is to build an integrated group of subcontractors serving healthcare players. The Group's headquarters are based in Leuven, Belgium. More information is available at www.oxurion.com. Important information about forward-looking statements Certain statements in this press release may be considered “forward-looking”. Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Company's Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. state securities laws. Additional Disclaimer The planned investment in digital assets (such as Bitcoin and Ethereum) exposes the company to specific risks related to volatility, regulatory uncertainty, and cybersecurity. These factors may significantly affect the expected performance of the investments. For further information please contact:
Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière